NASDAQ:AHPI
Allied Healthcare Products, Inc.
- Stock
Market Cap
16.05K
Beta: −2.40
PE Ratio
0.00
PFCF: −0.01
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 9.37M - | 9.30M 0.79% | 9.03M 2.85% | 8.69M 3.76% | 8.17M 6.01% | 7.58M 7.21% | 8.13M 7.24% | 9.19M 13.02% | 8.96M 2.49% | |
average payables | 1.19M - | 1.22M 2.16% | 1.62M 32.68% | 1.65M 2.21% | 1.46M 11.83% | 1.47M 0.99% | 2.20M 49.83% | 2.42M 9.74% | 1.55M 35.74% | |
average receivables | 3.99M - | 3.66M 8.41% | 3.85M 5.15% | 3.74M 2.76% | 3.57M 4.64% | 3.47M 2.77% | 3.15M 9.29% | 3.03M 3.78% | 2.65M 12.32% | |
book value per share | 5.61 - | 5.16 8.07% | 4.55 11.70% | 4.03 11.42% | 3.49 13.53% | 2.96 15.05% | 2.21 25.33% | 2.64 19.16% | 1.30 50.53% | |
capex per share | -0.11 - | -0.04 67.81% | -0.02 29.66% | -0.01 78.80% | -0.15 - | -0.04 72.94% | -0.02 55.11% | |||
capex to depreciation | -0.34 - | -0.11 68.55% | -0.08 24.93% | -0.02 76.11% | -1.00 - | -0.29 71.06% | -0.17 42.36% | |||
capex to operating cash flow | 0.23 - | -0.17 174.42% | 0.42 341.72% | 0.03 92.69% | -0.95 - | 0.04 104.63% | 0.02 58.53% | |||
capex to revenue | -0.01 - | -0.00 66.98% | -0.00 30.62% | -0.00 77.26% | -0.02 - | -0.00 76.21% | -0.00 39.79% | |||
cash per share | 0.34 - | 0.51 49.25% | 0.42 16.48% | 0.25 41.55% | 0.03 86.33% | 0.05 43.60% | 0.65 1,230.28% | 0.18 72.07% | 0.83 356.75% | |
days of inventory on hand | 118.16 - | 118.16 0.00% | 113.30 4.11% | 115.26 1.73% | 104.66 9.20% | 101.61 2.92% | 123.80 21.85% | 118.26 4.48% | 126.11 6.64% | |
days payables outstanding | 13.42 - | 17.60 31.14% | 23.80 35.27% | 19.50 18.06% | 19.70 0.98% | 20.36 3.36% | 40.77 100.25% | 23.76 41.72% | 18.02 24.13% | |
days sales outstanding | 37.44 - | 36.92 1.37% | 41.70 12.93% | 36.76 11.84% | 40.65 10.59% | 36.96 9.09% | 35.66 3.51% | 29.57 17.07% | 31.98 8.15% | |
debt to assets | 0.14 - | 0.17 27.03% | 0.21 23.45% | 0.18 17.21% | 0.19 9.23% | 0.23 20.15% | 0.55 137.94% | 0.40 26.67% | 0.73 82.41% | |
debt to equity | 0.16 - | 0.21 32.64% | 0.27 29.77% | 0.21 20.88% | 0.24 11.42% | 0.30 26.19% | 1.22 305.63% | 0.67 44.62% | 2.76 309.71% | |
dividend yield | ||||||||||
earnings yield | -0.14 - | -0.14 2.37% | -0.48 239.33% | -0.18 62.37% | -0.23 25.86% | -0.28 23.53% | -0.06 77.23% | 0.10 258.13% | -0.82 912.95% | |
enterprise value | 18.06M - | 10.56M 41.51% | 3.11M 70.53% | 10.60M 240.66% | 9.54M 10.06% | 7.34M 23.03% | 47.07M 541.31% | 18.10M 61.55% | 5.70M 68.51% | |
enterprise value over ebitda | -9.68 - | -23.49 142.61% | -4.02 82.90% | -11.02 174.40% | -8.96 18.69% | -3.76 58.04% | -19.13 408.86% | 342.28 1,888.76% | -1.38 100.40% | |
ev to operating cash flow | -9.59 - | 12.97 235.22% | -13.13 201.26% | -15.44 17.53% | -11.09 28.13% | 123.69 1,214.90% | 72.69 41.23% | -4.78 106.58% | -1.39 70.91% | |
ev to sales | 0.50 - | 0.30 40.01% | 0.09 70.93% | 0.32 265.47% | 0.28 10.72% | 0.23 17.20% | 1.48 531.00% | 0.50 66.19% | 0.21 57.76% | |
free cash flow per share | -0.58 - | 0.17 129.00% | -0.08 149.95% | -0.18 110.53% | -0.21 21.42% | 0.01 106.90% | 0.01 49.83% | -0.98 13,372.76% | -1.04 5.57% | |
free cash flow yield | -0.12 - | 0.05 144.70% | -0.07 230.71% | -0.06 12.58% | -0.09 45.60% | 0.01 108.86% | 0.00 92.00% | -0.24 37,594.75% | -0.64 170.08% | |
graham net net | 1.33 - | 1.25 5.89% | 1.07 14.54% | 1.08 0.80% | 0.88 18.13% | 0.67 24.40% | -0.35 151.92% | 0.13 138.35% | -1.27 1,056.36% | |
graham number | 9.39 - | 7.17 23.69% | 7.67 7.01% | 6.87 10.40% | 6.55 4.73% | 5.92 9.58% | 6.11 3.29% | 4.99 18.33% | 6.26 25.38% | |
income quality | 0.67 - | -0.46 168.29% | 0.10 122.44% | 0.33 219.86% | 0.39 19.23% | -0.03 107.17% | -0.21 663.82% | -2.24 943.92% | 0.76 134.07% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -84.67 - | -49.34 41.73% | -47.34 4.05% | -4.54 90.41% | -23.92 426.87% | |||||
interest debt per share | 0.01 - | 0.01 138.55% | 0.61 4,269.86% | 0.55 10.19% | 0.66 20.83% | |||||
inventory turnover | 3.09 - | 3.09 0.00% | 3.22 4.29% | 3.17 1.70% | 3.49 10.13% | 3.59 3.00% | 2.95 17.93% | 3.09 4.69% | 2.89 6.23% | |
invested capital | 0.27 - | 0.20 26.66% | 0.47 139.28% | |||||||
market cap | 19.43M - | 12.60M 35.12% | 4.82M 61.78% | 11.60M 140.83% | 9.67M 16.61% | 7.54M 22.10% | 47.28M 527.43% | 16.74M 64.60% | 6.54M 60.91% | |
net current asset value | 11.39M - | 10.85M 4.74% | 10.02M 7.67% | 9.75M 2.70% | 8.65M 11.23% | 7.39M 14.63% | 4.08M 44.76% | 6.26M 53.45% | 1.65M 73.73% | |
net debt to ebitda | 0.73 - | 4.54 519.10% | 2.20 51.54% | 1.03 52.92% | 0.13 87.64% | 0.10 21.71% | 0.08 15.60% | 25.80 30,426.20% | 0.20 99.21% | |
net income per share | -0.70 - | -0.44 36.66% | -0.57 29.68% | -0.52 9.38% | -0.55 4.96% | -0.53 3.76% | -0.75 42.87% | 0.42 155.98% | -1.34 417.77% | |
operating cash flow per share | -0.47 - | 0.20 143.26% | -0.06 129.10% | -0.17 189.86% | -0.21 25.14% | 0.01 106.90% | 0.16 991.27% | -0.94 684.35% | -1.02 8.25% | |
payables turnover | 27.20 - | 20.74 23.74% | 15.33 26.07% | 18.71 22.04% | 18.53 0.97% | 17.93 3.25% | 8.95 50.06% | 15.36 71.58% | 20.25 31.81% | |
receivables turnover | 9.75 - | 9.89 1.39% | 8.75 11.45% | 9.93 13.43% | 8.98 9.58% | 9.88 10.00% | 10.24 3.64% | 12.34 20.58% | 11.41 7.53% | |
research and ddevelopement to revenue | ||||||||||
return on tangible assets | -0.11 - | -0.07 34.01% | -0.10 39.71% | -0.11 7.05% | -0.13 18.99% | -0.14 7.87% | -0.15 12.23% | 0.10 162.21% | -0.27 385.97% | |
revenue per share | 9.06 - | 8.84 2.50% | 8.96 1.38% | 8.35 6.79% | 8.41 0.74% | 7.82 7.05% | 7.95 1.63% | 9.04 13.75% | 6.74 25.45% | |
roe | -0.12 - | -0.09 31.10% | -0.13 46.86% | -0.13 2.30% | -0.16 21.37% | -0.18 13.29% | -0.34 91.33% | 0.16 146.98% | -1.02 742.33% | |
roic | -0.12 - | -0.09 29.86% | -0.12 40.80% | -0.13 4.61% | -0.14 7.94% | -0.21 48.77% | -0.25 22.99% | -0.04 86.18% | -0.44 1,139.45% | |
sales general and administrative to revenue | 0.29 - | 0.25 13.77% | 0.26 4.44% | 0.26 0.48% | 0.25 2.60% | |||||
shareholders equity per share | 5.61 - | 5.16 8.07% | 4.55 11.70% | 4.03 11.42% | 3.49 13.53% | 2.96 15.05% | 2.21 25.33% | 2.64 19.16% | 1.30 50.53% | |
stock based compensation to revenue | 0.00 - | 0.00 47.35% | 0.00 41.37% | 0.00 9.29% | 0.00 12.77% | 0.00 17.73% | 0.00 23.27% | 0.00 409.86% | 0.00 49.85% | |
tangible asset value | 22.51M - | 20.69M 8.07% | 18.27M 11.70% | 16.19M 11.42% | 14.00M 13.53% | 11.89M 15.05% | 8.88M 25.33% | 10.58M 19.16% | 5.23M 50.53% | |
tangible book value per share | 5.61 - | 5.16 8.07% | 4.55 11.70% | 4.03 11.42% | 3.49 13.53% | 2.96 15.05% | 2.21 25.33% | 2.64 19.16% | 1.30 50.53% | |
working capital | 11.39M - | 10.85M 4.74% | 10.02M 7.67% | 9.75M 2.70% | 8.65M 11.23% | 7.39M 14.63% | 5.95M 19.47% | 6.27M 5.40% | 10.10M 61.06% |
All numbers in USD (except ratios and percentages)